Product Information
ARMODAFINIL 200 MG TABLET is a generic product labeled by Natco Pharma USA LLC, priced at $0.8028 per EA under NDC 69339017903. Its NADAC has been published 179 times since May 3, 2023.
FDA first approved this application on Nov 28, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Natco Pharma USA LLCNDC
69339017903
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ARMODAFINILApproval Type
Generic (ANDA)
FDA Application
ANDA202768FDA Approved
11/28/2016
TE Code
AB
On Market Since
3/23/2023
Price Statistics
The NADAC for ARMODAFINIL 200 MG TABLET has been published 179 times since May 3, 2023, and over the history we have for it it has declined 4.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8028 per EA |
|---|---|
| All-time high | $0.8705 (Nov 12, 2025) |
| All-time low | $0.5172 (Nov 20, 2024) |
| 52-week high | $0.8705 |
| 52-week low | $0.8028 |
| Median price | $0.7627 |
| Average price | $0.7527 |
| Largest weekly change | +34.7% (Aug 21, 2024) |
| Weeks tracked | 179 |
| Tracking since | May 3, 2023 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Natco Pharma USA LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Armodafinil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ARMODAFINIL 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ARMODAFINIL 200 MG TABLET, manufactured by Natco Pharma USA LLC, is $0.8028 per EA (NDC 69339017903), effective Sep 30, 2026.
How has the price of ARMODAFINIL 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for ARMODAFINIL 200 MG TABLET has declined 4.6%. It has been tracked across 179 weekly CMS publications since May 3, 2023.
What are the highest and lowest recorded NADAC prices for ARMODAFINIL 200 MG TABLET?
Since May 3, 2023, the NADAC for ARMODAFINIL 200 MG TABLET has ranged from a low of $0.5172 (Nov 20, 2024) to a high of $0.8705 (Nov 12, 2025), with a median of $0.7627 per EA.
Are there cheaper alternatives to ARMODAFINIL 200 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ARMODAFINIL 200 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ARMODAFINIL 200 MG TABLET?
ARMODAFINIL 200 MG TABLET (NDC 69339017903) is labeled by Natco Pharma USA LLC, and CMS classifies it as a generic product.